Accès gratuit
Med Sci (Paris)
Volume 28, Numéro 6-7, Juin–Juillet 2012
Page(s) 580 - 582
Section Nouvelles
Publié en ligne 16 juillet 2012
  1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 ; 340 : 115–126. [CrossRef] [PubMed]
  2. Clarke MC, Talib S, Figg NL, Bennett MR. Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ Res 2010 ; 106 : 363–372. [CrossRef] [PubMed]
  3. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010 ; 464 : 1357–1361. [CrossRef] [PubMed]
  4. Ridker PM, Thuren T, Zalewski A, Libby P. Interleukin-1 beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab anti-inflammatory thrombosis outcomes study (CANTOS). Am Heart J 2011 ; 162 : 597–605. [CrossRef] [PubMed]
  5. Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol 2009 ; 36 : 1118–1125. [CrossRef] [PubMed]
  6. Lawrie A, Hameed AG, Chamberlain J, et al. Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. Am J Pathol 2011 ; 179 : 1693–1705. [CrossRef] [PubMed]
  7. Saxena A, Rauch U, Berg KE, et al. The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res 2011 ; 91 : 350–357. [CrossRef] [PubMed]
  8. Alexander MR, Moehle CW, Johnson JL, et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest 2012 ; 122 : 70–79. [CrossRef] [PubMed]
  9. Lacolley P, Regnault V, Nicoletti A, et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 2012 (sous-presse).
  10. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 ; 12 : 178–180. [CrossRef] [PubMed]
  11. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 ; 109 : 745–753. [CrossRef] [PubMed]
  12. Ho-Tin-Noé B, Le Dall J, Gomez D, et al. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner. Circ Res 2011 ; 109 : 1003–1014. [CrossRef] [PubMed]
  13. Le Dall J, Ho-Tin-Noé B, Louedec L, et al. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. Cardiovasc Res 2010 ; 85 : 184–193. [CrossRef] [PubMed]
  14. Tréguer K, Heydt S, Hergenreider E. Protection des vaisseaux sanguins contre l’athérosclérose : le rôle des miARN sécrétés par l’endothélium. Med Sci (Paris) 2012 ; 28 : 584–587. [CrossRef] [EDP Sciences] [PubMed]